Cellibre, Inc. — Form D
Cellibre, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-08. The offering totals $15.0M, of which $9.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-09-08
- Form: D
- Accession: 0001781232-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $9.9M
- Remaining: $5.1M
- Minimum investment: $5K
- Investors: 35
- Date of first sale: 2021-08-31
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-412664
Issuer
- Name: Cellibre, Inc.
- CIK: 0001781232
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 6825 FLANDERS DRIVE, SAN DIEGO, CA, 92121
- Phone: 916-539-5454
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Nicky Caiazza | Director | Encinitas, CA |
| Nicky Caiazza | Executive Officer | Encinitas, CA |
| Scott Zingheim | Director | La Jolla, CA |
| Scott Zingheim | Executive Officer | La Jolla, CA |
| Spiros Kambourakis | Director | San Diego, CA |
| Spiros Kambourakis | Executive Officer | San Diego, CA |
| Benjamin Chiarelli | Director | Rancho Santa Fe, CA |
| Benjamin Chiarelli | Executive Officer | Rancho Santa Fe, CA |
Other filings by this issuer (2)
More